Results 131 to 140 of about 2,661 (192)

Bionic design based on liposome-exosome hybrid nanoparticles for synergistic delivery of paeonol to achieve neuroprotection and improvement of motor function in Parkinson's disease model mice. [PDF]

Mater Today Bio
Wu Y, Wang C, Fang K, Zu R, Deng Y, Hu C, Cao K, Fang Y, Chen X, Liu Y, Zhang Y, Sun B, Wang L, Shen W, Xia H.   +14 more
europepmc   +1 more source

Paeonol and Its Metabolites Alleviate LPS/D-GalN-Induced Acute Liver Injury in Mice: Potential Involvement of NDUFS7 and Macrophage Mitochondrial Function. [PDF]

Antioxidants (Basel)
Lyu XR, Xu ST, Su N, Lin M, Zhao ZY, Xu ZH, Li X, Lu ZH, Wei TT, Zhang SY, Fu Q, Wang GJ, Peng Y, Sun JG.   +13 more
europepmc   +1 more source

Paeonol Ameliorates Benign Prostatic Hyperplasia via Suppressing Proliferation and NF-κB-In Silico and Experimental Studies. [PDF]

Pharmaceuticals (Basel)
Lee HY, Lee MS, Lee BC.
europepmc   +1 more source

Integrative RNA-seq and LASSO-COX analysis reveal Paeonol's key target gene in proliferation suppression and apoptosis-induced in cervical cancer. [PDF]

Front Pharmacol
Li M, Gao N, Xu L, Ge P, Jiang N, Shang Y.   +5 more
europepmc   +1 more source

Paeonol Inhibits Cell Growth by Inducing Ferroptosis in Human Glioma Cells. [PDF]

Pharmacol Res Perspect
Li X, Liao XQ, Chen WR, Wu T, Li JX, Wang L, He BS, Qin X, Luo JQ.   +8 more
europepmc   +1 more source

Modified Jie-Yu-He-Huan Capsule in Post-Stroke Depression Treatment: Insights from DIA Proteomic and PRM Validation. [PDF]

Drug Des Devel Ther
Wang X, Gao Q, Liu C, Hu M, Liu Z, Li Z, Zhang H, Wu L, Chen K, Xu K, Geng X, Liu W, Wei S.   +12 more
europepmc   +1 more source

Anti-tumor efficacy of paeonol in endometrial cancer: a correspondence. [PDF]

Int J Surg
Xiao C, Zhang Y, Li Q.
europepmc   +1 more source

The Influence of the Drying Process on the Dissolution Time of Concentrated Chinese Medicine Pills: Roles of Textural Properties and Water Migration. [PDF]

Pharmaceutics
Wang X, Meng Q, Luo X, Zhang Y, Yang J, Rao X, Zhang Y, Lu H, He Y, Liu W.   +9 more
europepmc   +1 more source

Effective-Component Compatibility of Bufei Yishen Formula III Improves Chronic Obstructive Pulmonary Disease by Inhibiting Inflammatory Responses Through Blocking PTX3 Activation. [PDF]

J Inflamm Res
Lu R, Miao Y, Guan Q, Song M, Dong H, Tian Y, Ren Z, Zhang L.   +7 more
europepmc   +1 more source